Navigation Links
Magellan Biosciences Sells its Life Sciences Tools Business to Dionex

CHELMSFORD, Mass., Sept. 22 /PRNewswire/ -- Magellan Biosciences, Inc. (Magellan), an emerging leader in clinical diagnostics, has sold its ESA Life Sciences Tools (LST) business to Sunnyvale, California-based Dionex, Inc. (Nasdaq: DNEX). The sale includes all of ESA's HPLC-related products, HPLC clinical assays, the ESA Laboratories services and assets, as well as ESA's headquarters in Chelmsford, Massachusetts. Financial terms of the transaction were not disclosed.

"This sale enables Magellan to concentrate on our clinical-diagnostic customers. We can now apply all of our resources to developing and supporting innovation in diagnostic products that give clinicians the answers they need to make more-informed treatment decisions for superior, outcomes-based care," said Magellan President and Chief Executive Officer, Robert J. Rosenthal, Ph.D. "Stay tuned. Over the next several months we will be highlighting the new diagnostics-focused Magellan. In the meantime, customers can continue to count on the Magellan brands and people they've come to know: LeadCare((R) )for( )blood-lead-testing systems, Dynex((R)) for automated ELISA processing systems, and TREK for microbiology."

LeadCare - Because traditional prescription-based and send-out practices have missed those children most at-risk for lead poisoning, policy-makers at the federal, state, and local level are taking action to encourage the use of the LeadCare II system to ensure that children receive mandated testing. For example, New York State Medicaid just began reimbursing doctors and health clinics for LeadCare II tests. As a CLIA-waived test, the LeadCare II system removes all the complications formerly associated with blood-lead testing - waiting days for lab results, spending precious staff time and resources trying to contact patients for critical follow-up care, or tracking down results for record-keeping, reporting, or compliance purposes. Visit to learn more. For important lead-poisoning prevention resources, links to consumer product recall information, and tips for keeping children safe, visit

Dynex - The DS2(R) two-plate and DSX(R) four-plate ELISA processing systems are designed for efficiency and reliability with the 'expert' inside. They perform the most-sophisticated analyses, but are easy to use for operators with varying levels of education and experience. The DSX and DS2 are open systems with full walk-away automation and precise liquid-handling capabilities. They execute the entire complement of analytical steps required for virtually any ELISA immunoassay: adding samples and reagents, washing, incubation, and detection, delivering all you need to ensure the rigorous, repeatable analyses required in critical applications - from immunology to infectious disease, hormone, allergy, blood-chemistry, and drugs-of-abuse testing. To see a video of the DS2 at work, visit

TREK - The award-winning VersaTREK(R) automated microbial-detection system performs four tests on one automated platform: culture for blood, sterile body fluids, and mycobacteria detection, as well as Mycobacterium tuberculosis (TB) susceptibility testing. TREK's signature Sensititre(R) product line for susceptibility and identification testing enables labs to test - on a single cost-effective, LIS-compatible system - more FDA-cleared antimicrobial drugs than on any other automated platform against the widest range of non-fastidious and fastidious bacteria and yeasts. This saves microbiology labs from having to use multiple off-line test procedures to obtain accurate susceptibility data. TREK's platform is the system-of-choice for global surveillance initiatives, including NARMS (National Antimicrobial Resistance Monitoring System). For more information on TREK products, visit

About Magellan (

An emerging leader in clinical-diagnostic markets for near-patient testing, hospital-based labs, and microbiology, Magellan serves customers worldwide with rapid point-of-care analyzers and consumables; blood culture, antimicrobic-susceptibility tests, systems, and reagents; as well as automated ELISA processing systems, microplate instrumentation, and associated consumables. We design all our products to deliver better, faster, more-reliable diagnostic results to help doctors make more-informed treatment decisions and improve health outcomes. Magellan brands include LeadCare, Dynex, and TREK.

SOURCE Magellan Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
2. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
3. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
4. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
5. Cell Biosciences Launches Unique Protein Phosphorylation Assay Service
6. Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions
7. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
8. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
9. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
10. BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research
11. ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries ... as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical ... November 29 to December 4, 2015. , MED-TAB is expected to change ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the millions of people ... Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister ... free catheter portfolio,” said Michael Gresavage, Vice President North America. "We designed our ...
(Date:12/1/2015)... ... 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, 2015) ... has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) service ... special needs providers that excel in synthesizing the areas of clinical quality, staff ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , Dec. 1, 2015  Six months of ... adolescents with type 1 diabetes, according to new research from ... . However, it may have a beneficial effect on measures ... the current issue of the Journal of the American ... date examining the effect of metformin on overweight and obese ...
(Date:12/1/2015)... Russia has always been a ... new drugs registered in Europe in 2015 were ... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... Russia has always been a country of choice for global ...
(Date:12/1/2015)... 1, 2015 Contraceptives ... Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, ... Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) ... Trends and Forecast 2014 - 2020 ", ... (TMR).The report states that the global contraceptives ...
Breaking Medicine Technology: